🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12572+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12572 recruiting trials

Phase 2RecruitingNCT05563467

Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.

🏥 Maria Sklodowska-Curie National Research Institute of Oncology📍 4 sites📅 Started Jan 2023View details ↗
Phase 3RecruitingNCT05613478

Camrelizumab Combined With Apatinib Mesylate and TACE in the Perioperative Treatment of Hepatocellular Carcinoma

👨‍⚕️ Xuehao Wang, professor, The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Jan 2023View details ↗
NARecruitingNCT06311708

Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

👨‍⚕️ Matthew Pollman, MD📍 20 sites📅 Started Jan 2023View details ↗
RecruitingNCT05478538

Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform

👨‍⚕️ Fred Hausheer, MD, FACP, Elephas📍 7 sites📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT05430698

PD-1 Antibody Plus GEMOX as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma

👨‍⚕️ Chao Liu, PhD, Department of Biliary and Pancreatic Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-sen University📍 1 site📅 Started Jan 2023View details ↗
Phase 1RecruitingNCT05679895

Safety and Efficacy of OC-1 Therapy in Patients With R/R T-ALL/LL

🏥 OneChain Immunotherapeutics📍 2 sites📅 Started Jan 2023View details ↗
RecruitingNCT06778343

Biomarkers in Inflammatory Rheumatic Diseases Diagnosis

🏥 Universidade Nova de Lisboa📍 1 site📅 Started Jan 2023View details ↗
EARLY_Phase 1RecruitingNCT05765981

An Early Clinical Trial to Evaluate VGN-R09b for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency.

👨‍⚕️ Jiwen Wang, Doctor, Shanghai Children's Medical Center, affiliated to Shanghai Jiao Tong University School of Medicine📍 1 site📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT05607407

Methimazole in Patients With Progressive Glioblastoma

👨‍⚕️ David Peereboom, MD, Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT05350865

Thailand HDV Cohort

👨‍⚕️ Anchalee Avihingsanon, MD, PhD, HIV-NAT, Thai Red Cross - AIDS Research Centre📍 4 sites📅 Started Jan 2023View details ↗
Enrolling by InvitationNCT05727852

Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases

🏥 I.M. Sechenov First Moscow State Medical University📍 1 site📅 Started Jan 2023View details ↗
Phase 1, PHASE2RecruitingNCT05470491

Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...

👨‍⚕️ Mustafa A Hyder, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Jan 2023View details ↗
Phase 1, PHASE2RecruitingNCT05455697

Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma

👨‍⚕️ Stephen D. Smith, Fred Hutch/University of Washington Cancer Consortium📍 1 site📅 Started Jan 2023View details ↗
Phase 1, PHASE2RecruitingNCT05674175

Co-administration of CART22-65s and huCART19 for B-ALL

👨‍⚕️ Regina Myers, MD, Children's Hospital of Philadelphia📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT05229432

Study of Gastric Motility in Eosinophilic Gastritis

👨‍⚕️ Paneez Khoury, MD, National Institutes of Health (NIH)📍 3 sites📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT05529069

Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients

👨‍⚕️ Preetesh Jain, MD, DM, PhD, M.D. Anderson Cancer Center📍 1 site📅 Started Jan 2023View details ↗
Phase 2RecruitingNCT05465954

Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma

👨‍⚕️ Jian L. Campian, MD, PhD, Mayo Clinic in Rochester📍 1 site📅 Started Jan 2023View details ↗
RecruitingNCT05752383

The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care

🏥 Centre Hospitalier Universitaire, Amiens📍 1 site📅 Started Jan 2023View details ↗
NAEnrolling by InvitationNCT05750667

Penn Family Screening for Familial Hypercholesterolemia

🏥 Northwestern University📍 1 site📅 Started Jan 2023View details ↗
NARecruitingNCT05572216

A CCafU-UroCCR Randomized Trial: 3D Image-Guided Robot-AssisTEd Partial Nephrectomy for Renal Complex Tumor (UroCCR N°99)

👨‍⚕️ Jean-Luc DESCOTES, Pr, University Hospital, Grenoble📍 2 sites📅 Started Jan 2023View details ↗
← PreviousPage 432 of 629Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →